MMP9 and ovarian carcinoma: Taken together, the data suggest that FBLN5 is degraded in epithelial ovarian cancer possibly by tumor macrophages that support tumor growth by degrading the matricellular protein thereby leading to increased angiogenesis and upregulation of MMP-9 to further support the invasive phenotype of EOC.